| Subgroup of studies | Anxiety vs. cannabis use/no use | Anxiety vs. CUD/no CUD (or no use) | ||||
---|---|---|---|---|---|---|---|
 |  | Nstudies | OR(95% CI) | p two-tailed | Nstudies | OR(95% CI) | p two-tailed |
Overall mean weighted OR | Â | 15 | 1.24 (1.06-1.45) | .006* | 13 | 1.68 (1.23-2.31) | .001* |
Subgroup analyses (Figure S3) | Â | Â | Â | Â | Â | Â | Â |
ORs adjusted for confounders | Yes | 12 | 1.24 (1.04-1.47) | .014* | 10 | 1.66 (1.17-2.37) | .005* |
 | No | 3 | 1.28 (.78-2.08) | .326 | 3 | 1.86 (1.10-3.15) | .021* |
 | Yes vs. No |  | Q(1) = .04; p = .848 |  |  | Q(1) = 8.96; p = .003* |  |
Clinical diagnosis of anxiety (based on DSM/ICD) | Yes | 9 | 1.29 (1.04-1.61) | .021* | 11 | 1.87 (1.43-2.44) | <.001* |
 | No | 6 | 1.17 (.93-1.48) | .186 | 2 | 1.14 (.78-1.66) | .509 |
 | Yes vs. No |  | Q(1) = .30; p = .586 |  |  | Q(1) = 36.91; p < .001* |  |
Meta-regression | Â | N studies | slope | slope p two-tailed | N studies | slope | slope p two-tailed |
Predictor: Year of publication Outcome: weighted OR | Â | Â | Â | Â | Â | Â | Â |
 |  | 15 | .02 | .299 | 13 | -.005 | .901 |